Dashboard
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 14.82% and Operating profit at -28.04% over the last 5 years
- The company is Net-Debt Free
2
Poor long term growth as Net Sales has grown by an annual rate of 14.82% and Operating profit at -28.04% over the last 5 years
3
With a fall in Net Sales of -21.26%, the company declared Very Negative results in Jun 26
4
Risky -
5
Below par performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
CNY 5,581 Million (Mid Cap)
NA (Loss Making)
NA
0.00%
-0.02
-20.41%
4.82
Revenue and Profits:
Net Sales:
53 Million
(Quarterly Results - Jun 2026)
Net Profit:
-29 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.67%
0%
-17.67%
6 Months
-30.7%
0%
-30.7%
1 Year
-10.23%
0%
-10.23%
2 Years
151.99%
0%
151.99%
3 Years
16.61%
0%
16.61%
4 Years
31.12%
0%
31.12%
5 Years
-38.64%
0%
-38.64%
Tinavi Medical Technologies Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.82%
EBIT Growth (5y)
-28.04%
EBIT to Interest (avg)
-29.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
0.15
Tax Ratio
23.51%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.43
EV to EBIT
-38.26
EV to EBITDA
-47.44
EV to Capital Employed
6.53
EV to Sales
27.15
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-17.06%
ROE (Latest)
-20.41%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
52.50
66.70
-21.29%
Operating Profit (PBDIT) excl Other Income
-37.50
-39.40
4.82%
Interest
3.80
1.50
153.33%
Exceptional Items
-0.10
0.30
-133.33%
Consolidate Net Profit
-29.50
-50.20
41.24%
Operating Profit Margin (Excl OI)
-951.50%
-764.40%
-18.71%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is -21.29% vs 126.87% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 41.24% vs -37.91% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
278.80
178.90
55.84%
Operating Profit (PBDIT) excl Other Income
-130.80
-115.00
-13.74%
Interest
16.80
9.20
82.61%
Exceptional Items
0.70
-0.20
450.00%
Consolidate Net Profit
-196.10
-121.10
-61.93%
Operating Profit Margin (Excl OI)
-645.10%
-883.30%
23.82%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 55.84% vs -13.99% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -61.93% vs 24.92% in Dec 2024
About Tinavi Medical Technologies Co., Ltd. 
Tinavi Medical Technologies Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






